Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review

被引:2
|
作者
Ding, Hanyi [1 ,2 ]
Liu, Na [3 ,5 ]
Wang, Yan [1 ,3 ]
Adam, Sofia Abdulkadir [3 ]
Jin, Jie [1 ,3 ,4 ]
Feng, Weiying [2 ]
Sun, Jie [1 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Zhejiang, Peoples R China
[2] Shaoxing Peoples Hosp, Dept Hematol, Shaoxing, Zhejiang, Peoples R China
[3] Key Lab Hematol Malignancies Diag & Treatment, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Prov Clin Res Ctr Hematol Disorders, Hangzhou, Zhejiang, Peoples R China
[5] Weifang Med Univ, Affiliated Hosp, Sch Clin Med, Dept Oncol, Weifang, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Pseudouridine; RNA modification; Pseudouridine synthase; Cancer diagnosis; Cancer treatment; MESSENGER-RNA; URINARY PSEUDOURIDINE; SERUM PSEUDOURIDINE; MODIFIED NUCLEOTIDES; TRANSLATION CONTROL; BIOCHEMICAL MARKER; DKC1; NUCLEOSIDES; DIAGNOSIS; EXPRESSION;
D O I
10.1186/s12967-024-05687-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundPseudouridine (Psi), a C5-glycoside isomer of uridine, stands as one of the most prevalent RNA modifications in all RNA types. Distinguishing from the C-N bond linking uridine to ribose, the link between Psi and ribose is a C-C bond, endowing Psi modified RNA distinct properties and functions in various biological processes. The conversion of uridine to Psi is governed by pseudouridine synthases (PUSs). RNA pseudouridylation is implicated in cancer biology and therapeutics.ObjectivesIn this review, we will summarize the methods for detecting Psi, the process of Psi generation, the impact of Psi modification on RNA metabolism and gene expression, the roles of dysregulated Psi and pseudouridine synthases in cancers, and the underlying mechanism.MethodsWe conducted a comprehensive search of PubMed from its inception through February 2024. The search terms included "pseudouridine"; "pseudouridine synthase"; "PUS"; "dyskerin"; "cancer"; "tumor"; "carcinoma"; "malignancy"; "tumorigenesis"; "biomarker"; "prognosis" and "therapy". We included studies published in peer-reviewed journals that focused on Psi detection, specific mechanisms involving Psi and PUSs, and prognosis in cancer patients with high Psi expression. We excluded studies lacking sufficient methodological details or appropriate controls.Results Psi has been recognized as a significant biomarker in cancer diagnosis and prognosis. Abnormal Psi modifications mediated by various PUSs result in dysregulated RNA metabolism and impaired RNA function, promoting the development of various cancers. Overexpression of PUSs is common in cancer cells and predicts poor prognosis. PUSs inhibition arrests cell proliferation and enhances apoptosis in cancer cells, suggesting PUS-targeting cancer therapy may be a potential strategy in cancer treatment.DiscussionHigh Psi levels in serum, urine, and saliva may suggest cancer, but do not specify the type, requiring additional lab markers and imaging for accurate diagnosis. Standardized detection methods are also crucial for reliable results. PUSs are linked to cancer, but more researches are needed to understand their mechanisms in different cancers. Anticancer treatments targeting PUSs are still under developed.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Pharmacogenomics revolutionizing cardiovascular therapeutics: A narrative review
    Inshutiyimana, Samuel
    Ramadan, Nagham
    Razzak, Rawane Abdul
    Al Maaz, Zeina
    Wojtara, Magda
    Uwishema, Olivier
    HEALTH SCIENCE REPORTS, 2024, 7 (10)
  • [22] Baclofen therapeutics, toxicity, and withdrawal: A narrative review
    Romito, Jia W.
    Turner, Emily R.
    Rosener, John A.
    Coldiron, Landon
    Udipi, Ashutosh
    Nohrn, Linsey
    Tausiani, Jacob
    Romito, Bryan T. F.
    SAGE OPEN MEDICINE, 2021, 9
  • [23] NITRIC-OXIDE BIOLOGY - IMPLICATIONS FOR CARDIOVASCULAR THERAPEUTICS
    WARREN, JB
    PONS, F
    BRADY, AJB
    CARDIOVASCULAR RESEARCH, 1994, 28 (01) : 25 - 30
  • [24] Implications of aneuploidy for stem cell biology and brain therapeutics
    Devalle, Sylvie
    Sartore, Rafaela C.
    Paulsen, Bruna S.
    Borges, Helena L.
    Martins, Rodrigo A. P.
    Rehen, Stevens K.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2012, 6
  • [25] RNA diagnostics and therapeutics: a comprehensive review
    Saju, Adeela Fathima
    Mukundan, Aditi
    Divyashree, M. S.
    Chandrashekhar, Raghu
    Rao, Archana Mahadev
    RNA BIOLOGY, 2025, 22 (01) : 1 - 11
  • [26] Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis
    Cicuttini, Flavia M.
    Proietto, Joseph
    Lim, Yuan Z.
    OSTEOARTHRITIS AND CARTILAGE OPEN, 2023, 5 (04):
  • [27] A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics
    Zhang, Yan-Ling
    Ma, Yan
    Zeng, You-Qin
    Liu, Yan
    He, En-Ping
    Liu, Yi-Tong
    Qiao, Feng-Ling
    Yu, Rong
    Wang, Ying-Shuang
    Wu, Xin-Yu
    Leng, Ping
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (22)
  • [28] The Impact of the Mediterranean Diet on Telomere Biology: Implications for Disease Management-A Narrative Review
    Baliou, Stella
    Ioannou, Petros
    Apetroaei, Miruna-Maria
    Vakonaki, Elena
    Fragkiadaki, Persefoni
    Kirithras, Evangelos
    Tzatzarakis, Manolis N.
    Arsene, Andreea Letitia
    Docea, Anca Oana
    Tsatsakis, Aristides
    NUTRIENTS, 2024, 16 (15)
  • [29] The promise of RNA-based therapeutics in revolutionizing heart failure management - a narrative review of current evidence
    Aderinto, Nicholas
    Abdulbasit, Muili O.
    Olatunji, Gbolahan
    Edun, Mariam
    Aboderin, Gbolahan
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (09): : 4442 - 4453
  • [30] HIV-Encoded Gene Therapy as Anti-cancer Therapeutics: A Narrative Review
    Balakrishnan, Pachamuthu
    Sathish, Sankar
    Saravanan, Shanmugam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)